Fig. 1From: Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trialWorkflow of the present study. pCR, pathological complete response; pM, non-carboplatin arm; pMCb, carboplatin armBack to article page